Everest Medicines Acquires Exclusive Rights to Novel Biologic for Eye Disorders Everest Medicines has acquired an exclusive license to develop and commercialize VIS-101, a novel bifunction…
Hong Kong Tennis Open: Last China Players Exit Zhang Shuai and Wang Yafan lost in straight sets, while top seed Belinda Bencic continued h…
Implementing Photobiomodulation for Dry AMD Dry age-related macular degeneration progresses slowly but relentlessly, resulting in meaningf…
Wizz Air Revives $580 Pass and Tests Business Class European budget airline Wizz Air has relaunched its popular ‘All You Can Fly’ membersh…
EU Tests Reveal Safety Risks in Low-Cost Products EU tests found major safety risks in low-cost products from Shein and Temu, with 69% fai…
Krafton's Shift to AI-First Company PUBG maker Krafton is investing ₩100 billion ($69 million) to become an AI-first company. The c…
DHS Agreement Reveals Risks of Using Social Security Data for Voter Citizenship Checks A recently released agreement gives the Department …
Alzheimer's Drug Approved by Health Canada Health Canada has conditionally approved the drug lecanemab to slow early-stage Alzheimer's dis…
Why Israel Lost the Gaza Opinion War Sacrificial violence crumbles under scrutiny in the modern world. In the war on Gaza, Israel p…